CR11123A - Compuestos triciclicos que contienen nitrogeno como agentes antibacteriales - Google Patents

Compuestos triciclicos que contienen nitrogeno como agentes antibacteriales

Info

Publication number
CR11123A
CR11123A CR11123A CR11123A CR11123A CR 11123 A CR11123 A CR 11123A CR 11123 A CR11123 A CR 11123A CR 11123 A CR11123 A CR 11123A CR 11123 A CR11123 A CR 11123A
Authority
CR
Costa Rica
Prior art keywords
containing nitrogen
antibacterial agents
compounds containing
tricycle
tricycle compounds
Prior art date
Application number
CR11123A
Other languages
English (en)
Spanish (es)
Inventor
David Evan Davies
David Thomas Davies
Ilaria Giordano
Alan Joseph Hennessy
Neil David Pearson
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39580226&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CR11123(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GB0707705A external-priority patent/GB0707705D0/en
Priority claimed from GB0720569A external-priority patent/GB0720569D0/en
Priority claimed from GB0805311A external-priority patent/GB0805311D0/en
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of CR11123A publication Critical patent/CR11123A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/16—Peri-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/06—Antibacterial agents for tuberculosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
    • C07D487/16—Peri-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Virology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
CR11123A 2007-04-20 2009-11-20 Compuestos triciclicos que contienen nitrogeno como agentes antibacteriales CR11123A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0707705A GB0707705D0 (en) 2007-04-20 2007-04-20 Compounds
GB0720569A GB0720569D0 (en) 2007-10-19 2007-10-19 Compounds
GB0805311A GB0805311D0 (en) 2008-03-20 2008-03-20 Compounds

Publications (1)

Publication Number Publication Date
CR11123A true CR11123A (es) 2010-03-08

Family

ID=39580226

Family Applications (2)

Application Number Title Priority Date Filing Date
CR11123A CR11123A (es) 2007-04-20 2009-11-20 Compuestos triciclicos que contienen nitrogeno como agentes antibacteriales
CR20150586A CR20150586A (es) 2007-04-20 2015-10-23 Compuestos triciclicos que contienen nitrogeno como agentes antibactercianos

Family Applications After (1)

Application Number Title Priority Date Filing Date
CR20150586A CR20150586A (es) 2007-04-20 2015-10-23 Compuestos triciclicos que contienen nitrogeno como agentes antibactercianos

Country Status (31)

Country Link
US (1) US8389524B2 (enExample)
EP (1) EP2137196B1 (enExample)
JP (1) JP5389013B2 (enExample)
KR (1) KR101567096B1 (enExample)
CN (1) CN101687887B (enExample)
AR (1) AR066111A1 (enExample)
AT (1) ATE483717T1 (enExample)
AU (1) AU2008240764C1 (enExample)
BR (1) BRPI0810064B8 (enExample)
CA (1) CA2684659C (enExample)
CL (1) CL2008001122A1 (enExample)
CO (1) CO6251368A2 (enExample)
CR (2) CR11123A (enExample)
CY (1) CY1111248T1 (enExample)
DE (1) DE602008002912D1 (enExample)
DK (1) DK2137196T3 (enExample)
DO (1) DOP2009000240A (enExample)
EA (1) EA015821B1 (enExample)
HR (1) HRP20100574T1 (enExample)
IL (1) IL201204A0 (enExample)
MA (1) MA31324B1 (enExample)
MX (1) MX2009011317A (enExample)
MY (1) MY149347A (enExample)
NZ (1) NZ579877A (enExample)
PE (1) PE20090274A1 (enExample)
PL (1) PL2137196T3 (enExample)
PT (1) PT2137196E (enExample)
SI (1) SI2137196T1 (enExample)
TW (1) TWI431006B (enExample)
UY (1) UY31038A1 (enExample)
WO (1) WO2008128942A1 (enExample)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080221110A1 (en) * 2005-10-21 2008-09-11 Nathalie Cailleau Compounds
EP1847543A1 (de) 2006-04-19 2007-10-24 Boehringer Ingelheim Pharma GmbH & Co. KG Dihydrothienopyrimidine zur Behandlung von entzündlichen Erkrankungen
GB0608263D0 (en) 2006-04-26 2006-06-07 Glaxo Group Ltd Compounds
JP5563466B2 (ja) 2007-10-19 2014-07-30 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 新規ピペラジノ−ジヒドロチエノピリミジン誘導体
SI2610258T1 (sl) 2007-10-19 2014-12-31 Boehringer Ingelheim International Gmbh Substituirani piperidino-dihidrotienopirimidini
JP5341899B2 (ja) 2007-10-19 2013-11-13 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング ヘテロ環置換ピペラジノ−ジヒドロチエノピリミジン
CA2713182C (en) 2008-02-20 2016-09-13 Actelion Pharmaceuticals Ltd Azatricyclic antibiotic compounds
MX2010012732A (es) * 2008-05-23 2010-12-07 Glaxo Group Ltd Compuestos que contienen nitrogeno triciclico y su uso como antibacterianos.
US20110071155A1 (en) * 2008-05-23 2011-03-24 Carlos Alemparte-Gallardo Tricyclic Nitrogen Containing Compounds And Their Use As Antibacterials
NZ592642A (en) 2008-10-07 2012-11-30 Actelion Pharmaceuticals Ltd Tricyclic oxazolidinone antibiotic compounds
EP2352734A1 (en) * 2008-10-17 2011-08-10 Glaxo Group Limited Tricyclic nitrogen compounds used as antibacterials
AU2010204723A1 (en) 2009-01-14 2011-08-18 The Salk Institute For Biological Studies Methods for screening and compounds that protect against amyloid diseases
AR076222A1 (es) 2009-04-09 2011-05-26 Actelion Pharmaceuticals Ltd Derivados 2-hidroxietil-1h-quinolin-ona y sus analogos azaisotericos con actividad antibacteriana y composiciones farmaceuticas que los contienen
TW201130854A (en) 2009-12-22 2011-09-16 Bayer Schering Pharma Ag Pyridinone derivatives and pharmaceutical compositions thereof
US8536328B2 (en) * 2010-05-04 2013-09-17 Alkermes Pharma Ireland Limited Process for synthesizing oxidized lactam compounds
US9802954B2 (en) 2011-08-24 2017-10-31 Boehringer Ingelheim International Gmbh Piperidino-dihydrothienopyrimidine sulfoxides and their use for treating COPD and asthma
US20130059866A1 (en) 2011-08-24 2013-03-07 Boehringer Ingelheim International Gmbh Novel piperidino-dihydrothienopyrimidine sulfoxides and their use for treating copd and asthma
CN103113291B (zh) * 2013-02-04 2015-03-04 浙江大学 一种3位烯基吡啶衍生物的合成方法
WO2015012210A1 (ja) * 2013-07-23 2015-01-29 エーザイ・アール・アンド・ディー・マネジメント株式会社 ヘテロ縮合環化合物
KR20170043603A (ko) * 2014-08-22 2017-04-21 글락소스미스클라인 인털렉츄얼 프로퍼티 디벨로프먼트 리미티드 네이세리아 고노레아에 감염을 치료하기 위한 트리시클릭 질소 함유 화합물
EP4186910A1 (en) * 2016-06-22 2023-05-31 Vanderbilt University Positive allosteric modulators of the muscarinic acetylcholine receptor m4
US11352349B2 (en) 2017-04-17 2022-06-07 Ohio State Innovation Foundation Type II topoisomerase inhibitors and methods of making and using thereof
CA3134801A1 (en) * 2019-04-03 2020-10-08 Glaxomithkline Intellectual Property Development Limited Gepotidacin for use in the treatment of bacterial urinary tract infections
BR112021024845A2 (pt) 2019-07-05 2022-01-18 Glaxosmithkline Ip Dev Ltd Combinação para o tratamento de infecções causadas por mycoplasma genitalium
EP4491231A3 (en) 2020-04-02 2025-04-09 Glaxosmithkline Intellectual Property Limited Regimen for treating a neisseria gonorrhoeae infection with gepotidacin
EP4143188A1 (en) 2020-04-29 2023-03-08 GlaxoSmithKline Intellectual Property Development Limited Crystalline forms of gepotidacin
CN111494241B (zh) * 2020-06-01 2023-03-24 湖北洁世达环保科技有限公司 一种纸巾柔润保湿液
CA3210313A1 (en) * 2021-02-05 2022-08-11 Glaxosmithkline Intellectual Property Development Limited Oral solid dose formulations
CA3240991A1 (en) 2022-01-21 2023-07-27 Nicole SCANGARELLA-OMAN Gepotidacin and vancomycin for use in the treatment of an infection caused by staphylococcus saprophyticus
EP4316463A1 (en) 2022-08-02 2024-02-07 GlaxoSmithKline Intellectual Property Development Limited Novel formulation
CA3259117A1 (en) 2022-09-26 2024-04-04 Glaxosmithkline Ip Dev Ltd GEPOTIDACIN INTENDED FOR USE IN THE TREATMENT OF BACTERIAL PROSTATITIS

Family Cites Families (66)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6403610B1 (en) 1999-09-17 2002-06-11 Aventis Pharma S.A. Quinolylpropylpiperidine derivatives, their preparation and the compositions which comprise them
US6525049B2 (en) 2000-07-05 2003-02-25 Pharmacia & Upjohn Company Pyrroloquinolones as antiviral agents
US6624159B2 (en) * 2000-07-12 2003-09-23 Pharmacia & Upjohn Company Heterocycle carboxamides as antiviral agents
IL154107A0 (en) 2000-07-26 2003-07-31 Smithkline Beecham Plc Aminopiperidine quinolines and their azaisosteric analogues with antibacterial activity
US6603005B2 (en) 2000-11-15 2003-08-05 Aventis Pharma S.A. Heterocyclylalkylpiperidine derivatives, their preparation and compositions containing them
GB0031088D0 (en) 2000-12-20 2001-01-31 Smithkline Beecham Plc Medicaments
EP1345903A1 (en) 2000-12-21 2003-09-24 Ciba SC Holding AG Crystalline forms of cerivastatin sodium
GB0101577D0 (en) 2001-01-22 2001-03-07 Smithkline Beecham Plc Compounds
US6602884B2 (en) 2001-03-13 2003-08-05 Aventis Pharma S.A. Quinolylpropylpiperidine derivatives, their preparation, and compositions containing them
GB0112836D0 (en) 2001-05-25 2001-07-18 Smithkline Beecham Plc Medicaments
GB0112834D0 (en) 2001-05-25 2001-07-18 Smithkline Beecham Plc Medicaments
GB0118238D0 (en) 2001-07-26 2001-09-19 Smithkline Beecham Plc Medicaments
WO2003048081A2 (en) 2001-12-04 2003-06-12 Bristol-Myers Squibb Company Glycinamides as factor xa inhibitors
AU2003239302A1 (en) 2002-01-29 2003-09-02 Glaxo Group Limited Aminopiperidine compounds, process for their preparation, and pharmaceutical compositions containing them
WO2003064421A1 (en) 2002-01-29 2003-08-07 Glaxo Group Limited Aminopiperidine derivatives
TW200409637A (en) * 2002-06-26 2004-06-16 Glaxo Group Ltd Compounds
TW200406413A (en) 2002-06-26 2004-05-01 Glaxo Group Ltd Compounds
GB0217294D0 (en) 2002-07-25 2002-09-04 Glaxo Group Ltd Medicaments
FR2844270B1 (fr) 2002-09-11 2006-05-19 Aventis Pharma Sa Derives de la quinolyl propyl piperidine, leur procede et intermediaires de preparation et les compositions qui les contiennent
FR2844268B1 (fr) 2002-09-11 2004-10-22 Aventis Pharma Sa Derives de la quinolyl propyl piperidine, leurs procedes et intermediaires de preparation et les compositions qui les contiennent
CN101817815A (zh) 2002-10-10 2010-09-01 莫弗凯姆联合化学股份公司 具有杀菌活性的化合物
DE60331849D1 (de) 2002-11-05 2010-05-06 Glaxosmithkline Llc Antibakterielle wirkstoffe
US7618959B2 (en) 2002-11-05 2009-11-17 Smithklinebeecham Corp Antibacterial agents
TW200427688A (en) 2002-12-18 2004-12-16 Glaxo Group Ltd Antibacterial agents
TW200507841A (en) 2003-03-27 2005-03-01 Glaxo Group Ltd Antibacterial agents
US7232833B2 (en) 2003-03-28 2007-06-19 Novexel 4-substituted quinoline derivatives, method and intermediates for their preparation and pharmaceutical compositions containing them
DE10316081A1 (de) 2003-04-08 2004-10-21 Morphochem AG Aktiengesellschaft für kombinatorische Chemie Neue Verbindungen mit antibakterieller Aktivität
US7348434B2 (en) 2003-08-08 2008-03-25 Antony Bigot 4-substituted quinoline derivatives, method and intermediates for their preparation and pharmaceutical compositions containing them
FR2867472B1 (fr) 2004-03-12 2008-07-18 Aventis Pharma Sa Derives de quinoleines-4-substituees, leurs procede et intermediaires de preparation et les compositions pharmaceutiques qui les contiennent
JP2008502689A (ja) 2004-06-15 2008-01-31 グラクソ　グループ　リミテッド 抗菌剤
FR2872164B1 (fr) 2004-06-29 2006-11-17 Aventis Pharma Sa Derives de quinoleines-4-substituees, leur procede et intermediaires de preparation et les compositions pharmaceutiques qui les contiennent
US20070254872A1 (en) 2004-07-08 2007-11-01 Glaxo Group Limited Antibacterial Agents
EP1773847A2 (en) 2004-07-09 2007-04-18 Glaxo Group Limited Antibacterial agents
WO2006017326A1 (en) 2004-07-13 2006-02-16 Glaxo Group Limited Antibacterial agents
EP1778688A1 (en) 2004-07-22 2007-05-02 Glaxo Group Limited Antibacterial agents
JP2008508359A (ja) 2004-08-02 2008-03-21 グラクソ グループ リミテッド 抗菌剤
EP1784410A4 (en) 2004-08-09 2009-07-15 Glaxo Group Ltd ANTIBACTERIAL AGENTS
DE102004041163A1 (de) 2004-08-25 2006-03-02 Morphochem Aktiengesellschaft für kombinatorische Chemie Neue Verbindungen mit antibakterieller Aktivität
JP4887297B2 (ja) 2004-09-24 2012-02-29 アクテリオン ファーマシューティカルズ リミテッド 新規二環式抗生物質
CN101039935B (zh) 2004-10-05 2011-04-20 埃科特莱茵药品有限公司 哌啶抗生素
WO2006046552A1 (ja) 2004-10-27 2006-05-04 Toyama Chemical Co., Ltd. 新規な含窒素複素環化合物およびその塩
WO2006081179A1 (en) 2005-01-25 2006-08-03 Glaxo Group Limited Antibacterial agents
WO2006081264A1 (en) 2005-01-25 2006-08-03 Glaxo Group Limited Antibacterial agents
WO2006081289A2 (en) 2005-01-25 2006-08-03 Glaxo Group Limited Antibacterial agents
WO2006081178A2 (en) 2005-01-25 2006-08-03 Glaxo Group Limited Antibacterial agents
EP1846418A4 (en) 2005-01-25 2009-12-23 Glaxo Group Ltd ANTIBACTERIAL ACTIVE SUBSTANCES
WO2006099884A1 (en) 2005-03-24 2006-09-28 Actelion Percurex Ag Beta-aminoalcohol antibiotics
US7842810B2 (en) 2005-03-31 2010-11-30 Janssen Pharmaceutica, Nv Bicyclic pyrazole compounds as antibacterial agents
MX2007014507A (es) 2005-05-24 2008-02-07 Astrazeneca Ab Aminopiperidin quinolinas y sus analogos azaisostericos con actividad antibacteriana.
JP2008542258A (ja) 2005-05-25 2008-11-27 アクテリオン ファーマシューティカルズ リミテッド 新規抗生物質誘導体
MY150958A (en) 2005-06-16 2014-03-31 Astrazeneca Ab Compounds for the treatment of multi-drug resistant bacterial infections
JP5398984B2 (ja) * 2005-06-24 2014-01-29 富山化学工業株式会社 新規な含窒素複素環化合物およびその塩
US20080221110A1 (en) * 2005-10-21 2008-09-11 Nathalie Cailleau Compounds
JP2009520779A (ja) 2005-12-22 2009-05-28 グラクソ グループ リミテッド 複素環化合物、その製造およびその抗菌剤としての使用
DE602007009205D1 (de) 2006-04-06 2010-10-28 Glaxo Group Ltd Pyrrolochinoxalinonderivate als antibakterielle mittel
US7709496B2 (en) 2006-04-06 2010-05-04 Glaxo Group Limited Antibacterial agents
GB0608263D0 (en) * 2006-04-26 2006-06-07 Glaxo Group Ltd Compounds
EP2029612A1 (en) 2006-06-09 2009-03-04 Glaxo Group Limited Substituted 1-methyl-1h-quinolin-2-ones and 1-methyl-1h-1,5-naphthyridin-2-ones as antibacterials
GB0613208D0 (en) 2006-07-03 2006-08-09 Glaxo Group Ltd Compounds
EP1992628A1 (en) 2007-05-18 2008-11-19 Glaxo Group Limited Derivatives and analogs of N-ethylquinolones and N-ethylazaquinolones
GB0705672D0 (en) 2007-03-23 2007-05-02 Glaxo Group Ltd Compounds
EP1980251A1 (en) 2007-04-13 2008-10-15 Glaxo Group Limited Pyrrolo[3,2,1-ij]quinoline-4-one derivatives for treating tuberculosis
GB0707706D0 (en) 2007-04-20 2007-05-30 Glaxo Group Ltd Compounds
GB0707708D0 (en) 2007-04-20 2007-05-30 Glaxo Group Ltd Compounds
EP2005995A1 (en) 2007-06-22 2008-12-24 Glaxo Group Limited Heterocyclic compounds for the treatment of tuberculosis
GB0800367D0 (en) 2008-01-09 2008-02-20 Glaxo Group Ltd Compounds

Also Published As

Publication number Publication date
JP5389013B2 (ja) 2014-01-15
BRPI0810064B1 (pt) 2021-03-30
DOP2009000240A (es) 2009-12-31
PT2137196E (pt) 2010-12-16
MY149347A (en) 2013-08-30
PE20090274A1 (es) 2009-04-03
AR066111A1 (es) 2009-07-22
WO2008128942A1 (en) 2008-10-30
UY31038A1 (es) 2008-11-28
DE602008002912D1 (de) 2010-11-18
CN101687887B (zh) 2012-08-29
EP2137196A1 (en) 2009-12-30
AU2008240764C1 (en) 2011-10-20
CO6251368A2 (es) 2011-02-21
CA2684659A1 (en) 2008-10-30
TW200848420A (en) 2008-12-16
AU2008240764B2 (en) 2011-04-07
HK1138000A1 (en) 2010-08-13
MX2009011317A (es) 2009-11-05
JP2010524884A (ja) 2010-07-22
EP2137196B1 (en) 2010-10-06
MA31324B1 (fr) 2010-04-01
CN101687887A (zh) 2010-03-31
AU2008240764A1 (en) 2008-10-30
KR20100017133A (ko) 2010-02-16
HRP20100574T1 (hr) 2010-12-31
EA200970987A1 (ru) 2010-04-30
DK2137196T3 (da) 2011-01-10
CR20150586A (es) 2016-04-04
US8389524B2 (en) 2013-03-05
NZ579877A (en) 2011-09-30
CL2008001122A1 (es) 2008-10-24
TWI431006B (zh) 2014-03-21
US20100137282A1 (en) 2010-06-03
EA015821B1 (ru) 2011-12-30
SI2137196T1 (sl) 2011-01-31
PL2137196T3 (pl) 2011-03-31
CY1111248T1 (el) 2015-06-11
CA2684659C (en) 2015-11-24
IL201204A0 (en) 2010-05-17
BRPI0810064A2 (pt) 2019-08-27
BRPI0810064B8 (pt) 2021-05-25
KR101567096B1 (ko) 2015-11-06
ATE483717T1 (de) 2010-10-15

Similar Documents

Publication Publication Date Title
CR11123A (es) Compuestos triciclicos que contienen nitrogeno como agentes antibacteriales
CR9930A (es) Compuestos
CL2007001995A1 (es) Compuestos derivados de pirrolotriazina; composicion farmaceutica que comprende a dichos compuestos; y su uso para tratar el cancer.
ECSP10010722A (es) Compuestos orgánicos
CL2007000311A1 (es) Compuestos derivados de cromen-2-ona; composicion farmaceutica que los comprende;y su uso en el trastamiento de un trastorno proliferativos como es el cancer.
CO6321189A2 (es) Compuestos de tiazol y oxazol de bencen-sulfonamida
SV2009003432A (es) Compuestos activos biciclicos 1,3-diones de herbicidas
ATE486079T1 (de) Azatricyclische verbindungen und deren verwendung
CR9786A (es) Compuestos de bencimidazol-tiofeno
CU20140090A7 (es) COMPUESTOS ß- LACTÁMICOS SUSTITUIDOS CON AMINA, SU PREPARACIÓN Y USO COMO AGENTES BACTERIANOS
EA201270308A1 (ru) Конъюгаты димеров пирроло [1,4]бензодиазепина в качестве противоракового средства
BRPI0814593A2 (pt) Composto, composição farmacêutica que o contém e uso do composto.
ATE507225T1 (de) Antibakterielle polycyclische harnstoffverbindungen
GT201000047A (es) Mejoras en compuestos organicos o relacionadas con los mismos
UY31688A1 (es) Plaguicidas
TW200801001A (en) Compounds
BRPI0810399A2 (pt) Composto, composição farmacêutica que o contém e uso do mesmo
BRPI0916571A2 (pt) composto derivado de alquilaminometiloxazolidinona tricíclo, medicamento e composição farmacêutica que o contém e uso do composto
CL2009000665A1 (es) Compuestos derivados de pirrolidinilo; composicion farmaceutica que comprende a dichos compuestos; y su uso en el tratamiento de la ansiedad, depresion o ambas.
DE502006004472D1 (de) Organische elektrolumineszenzvorrichtungen
GT200500385A (es) Aminoalcoholes triciclicos, procedimientos para su preparacion y su uso como inhibidores de inflamacion
CL2009001089A1 (es) Compuestos derivados de indolo[2,1-a][2]benzacepina; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto para el tratamiento de la hepatitis c.
CR20150080A (es) Derivados y analogos de n-etilquinolonas y n-etilazaquinolonas
CL2012001759A1 (es) Compuestos derivados de 8-hidroxiquinolina-7-carboxamida; composicion farmaceutica.
UY30235A1 (es) Inhibidores de la adenilato ciclasa soluble